Printer Friendly

Articles from The Fly (June 1, 2020)

1-122 out of 122 article(s)
Title Author Type Words
AbbVie enters strategic collaboration with Jacobio Pharmaceuticals. 207
Acreage Holdings enters two funding agreements for up to $60M gross proceeds. 429
Acuity Brands announces agreement with Ushio America. 330
Agree Realty receives May rent payments from 87% of its portfolio. 229
Aileron announces interim results from Phase 1b/2 trial of ALRN-6924. 491
Altimmune launches clinical trial of T-COVID intranasal immune modulator. 676
Amarin says cannot predict outcome of Vascepa generic appeal. 174
Amarin to increase Vascepa promotion and education initiatives. 220
American Campus says 93.3% of residents made May rent payments. 191
American Outdoor Brands changes name to Smith & Wesson Brands. 165
Asian Market Update:. 161
Asta Funding regains compliance with Nasdaq. 220
Autohome reports Q1 EPS 76c, consensus 76c. Financial report 162
Auxly Cannabis says established foundation to move towards positive cash flows. 207
Aveo Oncology announces FDA acceptance for NDA filing for tivozanib. 193
Baudax Bio secures $50M credit facility. 226
BioLineRx announces $4.39M registered direct offering. 181
Bombardier completes sale of CRJ program to Mitsubishi Heavy Industries. 219
Camber Energy, Viking Energy amend merger agreement. 560
Cancer Genetics reports Q4 EPS (14c) vs. ($4.08) last year. Financial report 300
Cancer Genetics: 'Substantial doubts' about ability continue as going concern. 193
Celyad presented updates on Phase 1 alloSHRINK trial at ASCO. 343
Chart Industries provides mid-Q2 business update. 562
Chi-Med plans to submit NDA for surufatinib following pre-NDA meeting with FDA. 170
Chuy's estimates positive EBITDA with average weekly sales above $54,000. 179
Chuy's reports Q2 SSS down approx. 49.8% vs. last year. 162
Chuy's says 87 dining rooms in operation at varying levels of capacity. 178
Codexis, Alphazyme partner to offer 'novel' enzymes to diagnostic markets. 279
Colliers International completes acquistion of Dougherty. 223
Delta 9 Cannabis completes transaction to acquire two Alberta stores. 327
Diffusion Pharmaceuticals regains compliance with Nasdaq requirement. 192
EIB, Voxeljet expand partnership to bring 3D printing into series production. 167
Eli Lilly doses first patients in LY-CoV555 study for COVID-19 treatment. 230
Emergent BioSolutions issued task order for COVID-19 vaccine development. 236
EnerSys reports Q4 EPS $1.11, consensus $1.18. Financial report 165
Era Group announces board approval to effect reverse stock split. 221
Erytech Pharma announces poster presentation ast ASCO. 216
FCC says C-band spectrum to be made available on accelerated timeline. Chronology 180
Ferroglobe announces 'unqualified' audit opinion including going concern. 330
Fiat Chrysler appoints Paolo Carmassi as CEO of Comau. 174
Flexsteel Industries implements conservative cash strategies amid COVID-19. 188
Fly Intel: Top five analyst downgrades. 237
Fly Intel: Top five analyst upgrades. 213
FX Action: The Canadian dollar has rallied. 263
FX Update: Both the dollar and yen weakened. 359
FX Update: The dollar and yen reversed course. 257
General Cannabis announces multi-million strategic equity investment. 379
Gilead announces topline results from Phase 3 SIMPLE trial. 368
Hancock Jaffe Laboratories announces intent to merge with Catheter Precision. 173
Histogen doses first patient in Phase 1b/2a trial of HST 001. 170
HollyFrontier announces expansion of renewables business. 398
iCAD hosts virtual roundtable event on breast cancer surgery. 263
Independence Realty Trust provides business update. 206
Intrepid Potash sells record volume of Trio to domestic customers in April. 189
ISS recommends OneSpaWorld shareholders vote "FOR" proposed equity financing. 153
ISS, Glass Lewis recommend Mack-Cali Realty shareholders vote gold proxy card. 232
Iterum says Phase 3 trial of sulopenem did not meet primary endpoint. 257
Kazia Therapeutics presents interim paxalisib Phase II data. 589
KKR to make $1B investment in Coty via convertible preferred shares. 272
Lexagene Holdings provides update on commercializing pathogen detection system. 229
Libbey files voluntary petitions under Chapter 11. 286
Ligand working with Gilead to meet need for remdesivir. 410
Lineage Cell Therapeutics reports findings from OpRegen study. 330
LiveXLive Media achieves triple-digit growth across core metrics. 162
Lufthansa executive board accepts German stabilization package. 227
Mallinckrodt to appeal District Court ruling. 400
Mayo Clinic joins Biomerica's InFoods IBS diagnostic-guided therapy trial. 564
Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment. 204
Mesa Labs reports Q4 EPS (37c), consensus 21c. Financial report 477
Mesoblast: Remestemcel-L improves respiratory, functional outcomes in COPD. 156
Muscle Maker to open four locations at Northern Virginia Community College. 158
Myovant Sciences submits NDA for relugolix combination tablet. 181
NextGen to evaluate returning to guidance. 287
NGL Energy Partners reports Q4 EPS ($2.09), consensus 13c. Financial report 191
Nordson acquires Fluortek, terms not disclosed. 168
Nordstrom temporarily closed stores, looks forward to serving customers 'soon'. 303
Novus Therapeutics announces OP0201 trial results, engages financial advisor. 230
Ocugen to discontinue Phase 3 oGVHD trial. 223
Pan American Silver resumes operations at Dolores, La Colorada mines. 245
Perceptron reports Q3 EPS (11c), consensus (6c). Financial report 187
PNM Resources backs FY20 ongoing EPS view of $2.16-$2.26, consensus $2.20. 309
PolarityTE announces publication of two SkinTE manuscripts. Clinical report 164
Primoris announces solar award with initial value of $10M. 176
ProPetro reports preliminary Q1 EPS (8c), consensus 20c. Financial report 183
Provectus presents data from metastatic uveal melanoma cohort of Phase 1 study. 459
Provectus publishes updated data from metastatic NET Phase 1 PV-10 study. 364
QTS Realty Trust announces 4M share forward common stock offering. 171
Regeneron, Intellia Therapeutics expand pact to develop CRISPR/Cas9 treatments. 228
Rekor Systems announces venture to launch. 175
Remdesivir now proven effective for COVID-19 in three studies, says Piper. 161
Revance, Mylan to advance development program for Botox biosimilar. 258
Rezolute present RZ358 clinical data-validated in PK, glycemic response in HI. 347
RH sees 'clear path to 20% operating margins over next few years'. 308
Satsuma Pharmaceuticals completes enrollment in Phase 3 Emerge trial. 155
Schultz Special Purpose reports LOI for combination with Clever Leaves. 303
Senior Facebook employees criticize Zuckerberg's inaction, Bloomberg reports. 179
Siga Technologies announces international delivery of oral TPOXX. 203
SL Green Realty provides update on collections, One Vanderbilt Avenue. 352
Spero Therapeutics announces inducement grants under Nasdaq listing rule. 221
Stitch Fix to cut about 1,400 jobs in California, WSJ reports. 160
Synlogic announces publication in Nature Communications highlighting SYNB1891. 213
Target temporarily closing or shortening hours at 200 stores. 237
The U.S. construction spending report. 239
The U.S. ISM rise to 43.1. 201
Thermon Group reports Q4 adj. EPS 1c, consensus 17c. Financial report 154
Tilray confirms closure of High Park Gardens facility in Leamington, Ontario. 212
Tonix selects Fujifilm Diosynth Biotechnologies as manufacturing partner. 179
Treasury Action: Treasuries are underwater to kick off the new month. 154
Treasury Market Outlook: U.S. markets are little changed to begin June. 214
Treasury's $117 B 3- and 6-month bill sales were mixed. 235
Twin River Worldwide to open nearly entire portfolio of operating casinos. 322
U.S. corporate bond update: Amazon leads a big list of issuers today. 203
U.S. equity futures are weaker. 166
U.S. ISM manufacturing index bounced 1.6 points to 43.1 in May. 151
VBL Therapeutics presents interim data from OVAL Phase 3 study. 190
Visa reports May total U.S. payments volume down 5% y/y. 235
Weingarten Realty says transformed portfolio 'very strong'. 293
Wesco, Anixter announce post-closing leadership team. 365
Xebec Adsorption, Fonds de solidarite FTQ launch investment fund. 180
Xperi, TiVo announce completion of merger, TIVO no longer listed for trading. 257
Yum China to introduce Beyond Burger at select restaurants. 206
Zynga to acquire Peak for $1.8B in cash, stock deal. 158

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters